Japanese biotech startup (Hokkaido University-certified, J-Startup HOKKAIDO) focused on drug discovery, NOT contract manufacturing. Develops GPCR-targeted antibody therapeutics using proprietary MoGRAA Discovery Engine technology. Has its own therapeutic pipeline including human CCR7 antibodies. This is a discovery-stage biotech company with partnerships (FRONTEO collaborative drug discovery), not a CDMO or service provider.
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.